Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 1

Conditions

Sleep Initiation and Maintenance Disorders 1Neoplasms 1Fatigue 1Breast Neoplasms 1Breast Carcinoma In Situ 1

Interventions

Cyclophosphamide 910Carboplatin 788pembrolizumab 747Paclitaxel 744Bevacizumab 716Cisplatin 709Gemcitabine 621Docetaxel 584Rituximab 558Radiotherapy 548Dexamethasone 511Nivolumab 491Doxorubicin 445Fluorouracil 392Capecitabine 382Etoposide 358Pemetrexed 339Cytarabine 335Oxaliplatin 335Lenalidomide 328Prednisone 327Erlotinib Hydrochloride 323fludarabine phosphate 316Trastuzumab 305Leucovorin 299fludarabine 296Vincristine 288Bortezomib 284Filgrastim 284Cetuximab 277

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Has results × Monitoring, Physiologic × Clear all
NCT02613364 2024-05-01

YOCAS-II

University of Rochester

Phase NA Completed
746 enrolled 32 charts

Sleep Initiation and Maintenance Disorders, Neoplasms

NCT02699983 2021-04-13

eHealth Weight Loss Program in African American Breast Cancer Survivors

Rutgers, The State University of New Jersey

Phase NA Completed
35 enrolled 35 charts
Breast

Breast Carcinoma In Situ, Breast Neoplasms

NCT02688192 2021-04-09

TLCFIT

Rutgers, The State University of New Jersey

Phase NA Completed
49 enrolled 14 charts

Fatigue

Data powered by HemOnc (CC BY 4.0) Colophon âš¡